top of page
ICD Pharma is developing Cannabis-based medicines, which will soon be available for patients and doctors around the world.
Our product pipeline includes Cannabis-based products in unique formulations, based on a portfolio of proprietary pharmaceutical delivery technologies, developed to address a variety of unmet clinical needs.
Based on many years of pharmaceutical development and with a track record of numerous drugs brought to market, we are creating a portfolio of best-in-class Cannabis-based therapies relying on novel formulations.
ICD Pharma's vision is to become a global leader in development of Cannabis based medicines for better, more effective and patient friendly care.
What we do
What we do
• Breakthrough technologies • Improved performance
• Better patient experience
What Patients Say
"It is always a battle to give Jane the oil, she dislikes the taste and when we mixed it with yogurt and other food, we never know how much she really consumes.
I wish there was non-oily, tasty syrup that she can take with a smile"
ICD Pharma Founders
Get in Touch
injecting Science into Cannabis and Improving Patients Care.
bottom of page